Home

Paul Herendeen

CIK 1374175 · EVP and CFO · last filed 2026-08-10

Paul Herendeen is an EVP and CFO who has filed 59 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing shows the insider bought $236.8K of ELAN on Aug 10, 2026. Across all open-market trades the lifetime net is +$613.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions. 19 SEC filings were submitted jointly with Bausch Health Companies Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.07M

Companies

5

Total Filings

59

Lifetime Open-Market Net

$613.2K

Filer Profile

Reported Address
C/O BAUSCH HEALTH COMPANIES INC.
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Related Filers
Bausch Health Companies Inc. — 19 joint filings, latest 2021-03-10
Elanco Animal Health Inc — 9 joint filings, latest 2026-08-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ELAN Director 111,687 $22.57 $2.52M $236.8K 5 2026-08-10
Elanco Animal Health Inc (ELAT) Delisted Director 35,956 $21.32 $766.6K $150.2K 3 2022-12-02
BHC EVP and CFO 446,137 $5.71 $2.55M $226.1K 13 2021-03-10
ZTS Exec. V.P. and CFO — $71.61 — $0 10 2016-07-20
Warner Chilcott plc (WCRX) Delisted Exec. V.P. and CFO 893,992 — — $0 1 2009-01-22

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-10 ELAN Buy (P) +10,000 $236.8K EDGAR
2026-05-26 ELAN Grant (A) +16,874 $0 EDGAR
2025-12-02 ELAN Grant (A) +10,314 $0 EDGAR
2024-12-03 ELAN Grant (A) +18,169 $0 EDGAR
2023-12-04 ELAN Grant (A) +20,374 $0 EDGAR
2022-12-02 Elanco Animal Health Inc (ELAT) Delisted Grant (A) +18,649 $0 EDGAR
2022-09-09 Elanco Animal Health Inc (ELAT) Delisted Buy (P) +10,000 $150.2K EDGAR
2021-12-02 Elanco Animal Health Inc (ELAT) Delisted Grant (A) +7,307 $0 EDGAR
2021-03-10 BHC Mixed +40,323 -$1.96M EDGAR
2021-03-05 BHC Grant (A) +63,439 $0 EDGAR
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.